Advertisement

Other Well-Defined Immunodeficiencies

  • Mehdi Yeganeh
  • Eleonora Gambineri
  • Kamran Abolmaali
  • Banafshe Tamizifar
  • Teresa Español
  • DNA repair mechanisms are critical for immune system maturation. In the absence of genomic stability, not only lymphocyte maturation is imperfect, but other system anomalies and malfunctions would also appear. These include neurodegeneration, growth retardation and cancer predisposition.

  • Di George syndrome is caused by chromosomal deletions on 22q11. The patients do not develop thymus normally and lack parathyroide glands. Cellular immunodeficiency is accompanied by congenital anomalies and hypocalcemia.

  • Wiskott-Aldrich syndrome is an X-linked disorder due to a defective cytoskeleton. The patients are characterized by persistent thrombocytopenia with small platelets, eczema, cellular and humoral immunodeficiency, and autoimmunity.

  • Hyper-IgE syndrome is a human disease of improper cytokine signaling with recurrent skin abscesses, pneumonia and elevated levels of IgE in serum. The syndrome includes other organ defects such as skeletal deformities.

  • Immuno-osseous dysplasias are characterized by association of immunodeficiency and skeletal problems. These patients have variable defects in both humoral and cellular immunity.

  • Chronic mucocutaneous candidiasis is a primary susceptibility to fungal infections and could be inherited in an autosomal dominant or recessive mode. Recurring infections of the skin and mucous membranes with yeasts, mostly Candida albicans, is the common feature.

  • Netherton syndrome is characterized by trichorrhexis invaginata, atopic dermatitis and eczema, high levels of IgE, angioedema, and immunodeficiency.

  • Høyeraal-Hreidarsson syndrome is characterized by cerebellar hypoplasia, psychomotor retardation, microcephaly, growth failure, and progressive pancytopenia.

Keywords

Ataxia Telangiectasia Mutate Primary Immunodeficiency Disease DiGeorge Syndrome Nijmegen Breakage Syndrome Autosomal Recessive 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The International Nijmegen Breakage Syndrome Study Group (TINBSSG) (2000) Nijmegen breakage syndrome. Arch Dis Child 82:400–406Google Scholar
  2. 2.
    Aalfs CM, van den BH, Barth PG, Hennekam RC (1995) The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. Eur J Pediatr 154:304–308PubMedGoogle Scholar
  3. 3.
    Aaltonen J, Komulainen J, Vikman A, Palotie A, Wadelius C, Perheentupa J, Peltonen L (1993) Autoimmune polyglandular disease type I. Exclusion map using amplifiable multiallelic markers in a microtiter well format. Eur J Hum Genet 1:164–171PubMedGoogle Scholar
  4. 4.
    Adachi M, Tachibana K, Masuno M, Makita Y, Maesaka H, Okada T, Hizukuri K, Imaizumi K, Kuroki Y, Kurahashi H, Suwa S (1998) Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion. Eur J Pediatr 157:34–38PubMedGoogle Scholar
  5. 5.
    Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, Anderson SM, Siegel RM, Candotti F, Schwartzberg PL (2007) Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol 124:41–48PubMedGoogle Scholar
  6. 6.
    Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836PubMedGoogle Scholar
  7. 7.
    Aihara Y, Mori M, Katakura S, Yokota S (1998) Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia. J Interferon Cytokine Res 18:561–563PubMedGoogle Scholar
  8. 8.
    Aldrich RA, Steinberg AG, Campbell DC (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13:133–139PubMedGoogle Scholar
  9. 9.
    Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ (2001) Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137:747–750PubMedGoogle Scholar
  10. 10.
    Alter BP (1996) Aplastic anemia, pediatric aspects. Oncologist 1:361–366PubMedGoogle Scholar
  11. 11.
    Alter BP, Gardner FH, Hall RE (1997) Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. Br J Haematol 97:309–311PubMedGoogle Scholar
  12. 12.
    Ariga T, Yamada M, Wada T, Saitoh S, Sakiyama Y (1999) Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome. Br J Haematol 104:893–900PubMedGoogle Scholar
  13. 13.
    Arkwright PD, Abinun M, Cant AJ (2002) Autoimmunity in human primary immunodeficiency diseases. Blood 99:2694–2702PubMedGoogle Scholar
  14. 14.
    Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 102:15960–15964PubMedGoogle Scholar
  15. 15.
    Atkinson TP, Schaffer AA, Grimbacher B, Schroeder HW, Jr., Woellner C, Zerbe CS, Puck JM (2001) An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family. Am J Hum Genet 69:791–803PubMedGoogle Scholar
  16. 16.
    Azzari C, Gambineri E, Resti M, Moriondo M, Betti L, Saldias LR, AM GG, Vierucci A (2005) Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome). Vaccine 23:1668–1671PubMedGoogle Scholar
  17. 17.
    Baldini A (2002) DiGeorge syndrome: the use of model organisms to dissect complex genetics. Hum Mol Genet 11:2363–2369PubMedGoogle Scholar
  18. 18.
    Barrett DJ, Ammann AJ, Wara DW, Cowan MJ, Fisher TJ, Stiehm ER (1981) Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 6:1–6PubMedGoogle Scholar
  19. 19.
    Bensoussan D, Le Deist F, Latger-Cannard V, Gregoire MJ, Avinens O, Feugier P, Bourdon V, Andre-Botte C, Schmitt C, Jonveaux P, Eliaou JF, Stoltz JF, Bordigoni P (2002) T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol 117:899–906PubMedGoogle Scholar
  20. 20.
    Berthet F, Tuchschmid P, Boltshauser E, Seger RA (1995) The Hoyeraal-Hreidarsson syndrome: don’t forget the associated immunodeficiency. Eur J Pediatr 154:998PubMedGoogle Scholar
  21. 21.
    Bessler M, Wilson DB, Mason PJ (2004) Dyskeratosis congenita and telomerase. Curr Opin Pediatr 16:23–28PubMedGoogle Scholar
  22. 22.
    Betterle C, Zanchetta R (2003) Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 74:9–33PubMedGoogle Scholar
  23. 23.
    Bilora F, Petrobelli F, Boccioletti V, Pomerri F (2000) Moderate-dose intravenous immunoglobulin treatment of Job’s syndrome. Case report. Minerva Med 91:113–116PubMedGoogle Scholar
  24. 24.
    Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M, Hamel-Teillac D, Ansai S, Mitsuhashi Y, Taieb A, de PY, Zambruno G, Harper JI, Hovnanian A (2002) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352–361PubMedGoogle Scholar
  25. 25.
    Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, Al ST, Mariotti F, Mazereeuw-Hautier J, Boralevi F, Hohl D, Harper J, Bodemer C, D’Alessio M, Hovnanian A (2003) LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 12:2417–2430PubMedGoogle Scholar
  26. 26.
    Bloom D (1954) Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity. AMA Am J Dis Child 88:754–758PubMedGoogle Scholar
  27. 27.
    Bockman DE, Kirby ML (1985) Neural crest interactions in the development of the immune system. J Immunol 135:766s–768sPubMedGoogle Scholar
  28. 28.
    Boerkoel CF, Nowaczyk MJ, Blaser SI, Meschino WS, Weksberg R (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 78:118–122PubMedGoogle Scholar
  29. 29.
    Boerkoel CF, O’Neill S, Andre JL, Benke PJ, Bogdanovic R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Frund S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Ormala T, Rener-Primec Z, Santava A, Santos HG, Schmidt B, Smith GC, Spranger J, Zupancic N, Weksberg R (2000) Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 159:1–7PubMedGoogle Scholar
  30. 30.
    Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30:215–220PubMedGoogle Scholar
  31. 31.
    Bonafe L, Schmitt K, Eich G, Giedion A, Superti-Furga A (2002) RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. Clin Genet 61:146–151PubMedGoogle Scholar
  32. 32.
    Bong CN, Huang SC, Wang CL, Liu PM, Chen HH, Yang KD (2005) Cyclosporin A therapy in a case with hyperimmunoglobulin E and nephrotic syndrome. J Microbiol Immunol Infect 38:60–64PubMedGoogle Scholar
  33. 33.
    Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W, Galy A, Caignard A, Zitvogel L (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104:3267–3275PubMedGoogle Scholar
  34. 34.
    Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR (1998) The face of Job. J Pediatr 133:303–305PubMedGoogle Scholar
  35. 35.
    Borzy MS, Ridgway D, Noya FJ, Shearer WT (1989) Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol 9:386–392PubMedGoogle Scholar
  36. 36.
    Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O’Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107PubMedGoogle Scholar
  37. 37.
    Brown JJ, Datta V, Browning MJ, Swift PG (2004) Graves’ disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17:1575–1579PubMedGoogle Scholar
  38. 38.
    Brugnoni D, Franceschini F, Airo P, Cattaneo R (1998) Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol 37:807–808PubMedGoogle Scholar
  39. 39.
    Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JL, Puck JM (1997) Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130:378–387PubMedGoogle Scholar
  40. 40.
    Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59–70PubMedGoogle Scholar
  41. 41.
    Burns S, Cory GO, Vainchenker W, Thrasher AJ (2004) Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104:3454–3462PubMedGoogle Scholar
  42. 42.
    Businco L, Aiuti F, Franchi F, Frati C, Cavalieri R, Rezza E (1976) Clinical and immunological improvement in a patient with chronic mucocutaneous candidiasis treated with transfer factor. Allergol Immunopathol (Madr) 4:345–350Google Scholar
  43. 43.
    Calle Y, Chou HC, Thrasher AJ, Jones GE (2004) Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells. J Pathol 204:460–469PubMedGoogle Scholar
  44. 44.
    Canales L, Middlemas RO, III, Louro JM, South MA (1969) Immunological observations in chronic mucocutaneous candidiasis. Lancet 2:567–571PubMedGoogle Scholar
  45. 45.
    Cavadini P, Vermi W, Facchetti F, Fontana S, Nagafuchi S, Mazzolari E, Sediva A, Marrella V, Villa A, Fischer A, Notarangelo LD, Badolato R (2005) AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Investig 115:728–732PubMedGoogle Scholar
  46. 46.
    Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C (2001) A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86:4747–4752PubMedGoogle Scholar
  47. 47.
    Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA, Bucher-Laurent S, Delenda C, Vainchenker W, Danos O, Galy A (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 12:597–606PubMedGoogle Scholar
  48. 48.
    Chaudhuri J, Alt FW (2004) Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4:541–552PubMedGoogle Scholar
  49. 49.
    Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y, Harper JI, de PY, Hovnanian A (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142PubMedGoogle Scholar
  50. 50.
    Chavanas S, Garner C, Bodemer C, Ali M, Teillac DH, Wilkinson J, Bonafe JL, Paradisi M, Kelsell DP, Ansai S, Mitsuhashi Y, Larregue M, Leigh IM, Harper JI, Taieb A, Prost Y, Cardon LR, Hovnanian A (2000) Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet 66:914–921PubMedGoogle Scholar
  51. 51.
    Chipps BE, Saulsbury FT, Hsu SH, Hughes WT, Winkelstein JA (1979) Non-candidal infections in children with chronic mucocutaneous candidiasis. Johns Hopkins Med J 144:175–179PubMedGoogle Scholar
  52. 52.
    Chun HH, Gatti RA (2004) Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 3:1187–1196Google Scholar
  53. 53.
    Clewing JM, Antalfy BC, Lucke T, Najafian B, Marwedel KM, Hori A, Powel RM, Safo Do AF, Najera L, SantaCruz K, Hicks MJ, Armstrong DL, Boerkoel CF (2007) Schimke immuno-osseous dysplasia: a clinicopathological correlation. J Med Genet 44:122–130PubMedGoogle Scholar
  54. 54.
    Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, Lucke T, Alpay H, Andre JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Frund S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, Kasap B, Kilic SS, Lama G, Lamfers P, Loirat C, Majore S, Milford D, Morin D, Ozdemir N, Pontz BF, Proesmans W, Psoni S, Reichenbach H, Reif S, Rusu C, Saraiva JM, Sakallioglu O, Schmidt B, Shoemaker L, Sigaudy S, Smith G, Sotsiou F, Stajic N, Stein A, Stray-Pedersen A, Taha D, Taque S, Tizard J, Tsimaratos M, Wong NA, Boerkoel CF (2007) Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat 28:273–283PubMedGoogle Scholar
  55. 55.
    Cole HN, Rauschkolb JC, Toomey J (1930) Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Dermatol Syphilol 21:71–95Google Scholar
  56. 56.
    Comel NM (1949) Ichthyosis tinearis circumflexa. Dermatologica 98:133–136PubMedGoogle Scholar
  57. 57.
    Conley ME, Beckwith JB, Mancer JF, Tenckhoff L (1979) The spectrum of the DiGeorge syndrome. J Pediatr 94:883–890PubMedGoogle Scholar
  58. 58.
    Connor JM, Teague RH (1981) Dyskeratosis congenita. Report of a large kindred. Br J Dermatol 105:321–325PubMedGoogle Scholar
  59. 59.
    Cooper MD, Chae HP, Lowman JT, Krivit W, Good RA (1968) Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 44:499–513PubMedGoogle Scholar
  60. 60.
    Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I (2002) A novel DKC1 mutation, severe combined immunodeficiency (T + B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haematol 119:765–768PubMedGoogle Scholar
  61. 61.
    Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, Gautier J (2003) An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11:203–213PubMedGoogle Scholar
  62. 62.
    Cuneo BF, Driscoll DA, Gidding SS, Langman CB (1997) Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet 69:50–55PubMedGoogle Scholar
  63. 63.
    Curry CJ, O’Lague P, Tsai J, Hutchison HT, Jaspers NG, Wara D, Gatti RA (1989) ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome. Am J Hum Genet 45:270–275PubMedGoogle Scholar
  64. 64.
    da Fonseca MA (2000) Dental findings in the Schimke immuno-osseous dysplasia. Am J Med Genet 93:158–160PubMedGoogle Scholar
  65. 65.
    Davidson HR, Connor JM (1988) Dyskeratosis congenita. J Med Genet 25:843–846PubMedGoogle Scholar
  66. 66.
    Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M (2003) Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol 25:195–197PubMedGoogle Scholar
  67. 67.
    Davis SD, Schaller J, Wedgwood RJ (1966) Job’s Syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet 1:1013–1015PubMedGoogle Scholar
  68. 68.
    de la Chapelle A, Herva R, Koivisto M, Aula P (1981) A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 57:253–256PubMedGoogle Scholar
  69. 69.
    de Martino M, Galli L, Azzari C, Zammarchi E, Vierucci A (1994) Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome. Vox Sanguinis 67:317–319PubMedGoogle Scholar
  70. 70.
    de Moraes-Vasconcelos D, Orii NM, Romano CC, Iqueoka RY, Duarte AJ (2001) Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis. Clin Exp Immunol 123:247–253PubMedGoogle Scholar
  71. 71.
    Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, Wagberg F, Brattsand M, Hachem JP, Leonardsson G, Hovnanian A (2007) LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent Interaction. Mol Biol Cell 18:3607–3619PubMedGoogle Scholar
  72. 72.
    Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 79: 923Google Scholar
  73. 73.
    Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635–644PubMedGoogle Scholar
  74. 74.
    Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:789–790PubMedGoogle Scholar
  75. 75.
    Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE, Boogaerts MA, Fryns JP, You D, Rosen MK, Vandenberghe P (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27:313–317PubMedGoogle Scholar
  76. 76.
    Dhillon AS, Chapman S, Milford DV (2001) Cerebellar defect associated with Schimke immuno-osseous dysplasia. Eur J Pediatr 160:372–374PubMedGoogle Scholar
  77. 77.
    Digweed M, Sperling K (2004) Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) 3:1207–1217Google Scholar
  78. 78.
    Dokal I (2000) Dyskeratosis congenita in all its forms. Br J Haematol 110:768–779PubMedGoogle Scholar
  79. 79.
    Drachtman RA, Alter BP (1995) Dyskeratosis congenita. Dermatol Clin 13:33–39PubMedGoogle Scholar
  80. 80.
    Driscoll DA, Sullivan KE (2006) DiGeorge Syndrome: a chromosome 22q11.2 deletion syndrome. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: a molecular & cellular approach. Oxford University Press, New York, pp. 485–495Google Scholar
  81. 81.
    Dunkle LM, Arvin AM, Whitley RJ, Rotbart HA, Feder HM, Jr., Feldman S, Gershon AA, Levy ML, Hayden GF, McGuirt PV, et al. (1991) A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 325:1539–1544PubMedGoogle Scholar
  82. 82.
    Dupre L, Trifari S, Follenzi A, Marangoni F, Lain de Lera T, Bernad A, Martino S, Tsuchiya S, Bordignon C, Naldini L, Aiuti A, Roncarolo MG (2004) Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther 10:903–915PubMedGoogle Scholar
  83. 83.
    Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, de Saint Basile G, Delaunay J, Schwarz K, Casanova JL, Blanche S, Fischer A (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622–e627PubMedGoogle Scholar
  84. 84.
    Ehrlich M, Jackson K, Weemaes C (2006) Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 1:2PubMedGoogle Scholar
  85. 85.
    Ekholm IE, Brattsand M, Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56–63PubMedGoogle Scholar
  86. 86.
    Elizondo LI, Huang C, Northrop JL, Deguchi K, Clewing JM, Armstrong DL, Boerkoel CF (2006) Schimke immuno-osseous dysplasia: a cell autonomous disorder? Am J Med Genet A 140:340–348PubMedGoogle Scholar
  87. 87.
    Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M, German J (1995) The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell 83:655–666PubMedGoogle Scholar
  88. 88.
    Emanuel BS, McDonald-McGinn D, Saitta SC, Zackai EH (2001) The 22q11.2 deletion syndrome. Adv Pediatr 48:39–73PubMedGoogle Scholar
  89. 89.
    Engman MF (1926) A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syphilol 13:685–687Google Scholar
  90. 90.
    Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S (1997) Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol 78:413–414PubMedCrossRefGoogle Scholar
  91. 91.
    Facchetti F, Blanzuoli L, Vermi W, Notarangelo LD, Giliani S, Fiorini M, Fasth A, Stewart DM, Nelson DL (1998) Defective actin polymerization in EBV- transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol 185:99–107PubMedGoogle Scholar
  92. 92.
    Falck J, Coates J, Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434:605–611PubMedGoogle Scholar
  93. 93.
    Fartasch M, Williams ML, Elias PM (1999) Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 135:823–832PubMedGoogle Scholar
  94. 94.
    Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M (2005) Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet 14:307–318PubMedGoogle Scholar
  95. 95.
    Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18:347–361PubMedGoogle Scholar
  96. 96.
    Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringden O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM (2001) Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 97:1598–1603PubMedGoogle Scholar
  97. 97.
    Finocchi A, Di Cesare S, Romiti ML, Capponi C, Rossi P, Carsetti R, Cancrini C (2006) Humoral immune responses and CD27 + B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol 17:382–388PubMedGoogle Scholar
  98. 98.
    Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M (2004) Gene therapy for immunodeficiency diseases. Semin Hematol 41:272–278PubMedGoogle Scholar
  99. 99.
    Franceschini P, Martino S, Ciocchini M, Ciuti E, Vardeu MP, Guala A, Signorile F, Camerano P, Franceschini D, Tovo PA (1995) Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature. Eur J Pediatr 154:840–846PubMedGoogle Scholar
  100. 100.
    Franco S, Alt FW, Manis JP (2006) Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Amst) 5:1030–1041Google Scholar
  101. 101.
    Fryns JP (2000) Hypersplenism and portal hypertension with vena porta thrombosis in cartilage-hair hypoplasia (metaphyseal chondrodysplasia, McKusick type, MIM *250250). Genet Couns 11:277–278PubMedGoogle Scholar
  102. 102.
    Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K (1991) Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) 70:99–117Google Scholar
  103. 103.
    Geha R NL, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J (2007) Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120:776–794PubMedGoogle Scholar
  104. 104.
    Gennery AR (2006) Primary immunodeficiency syndromes associated with defective DNA double-strand break repair. Br Med Bull 77–78:71–85PubMedGoogle Scholar
  105. 105.
    Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ (2002) Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86:422–425PubMedGoogle Scholar
  106. 106.
    Gennery AR, Flood TJ, Abinun M, Cant AJ (2000) Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 25:1303–1305PubMedGoogle Scholar
  107. 107.
    Gennery AR, Slatter MA, Bhattacharya A, Jeggo PA, Abinun M, Flood TJ, Cant AJ (2005) Bone marrow transplantation for Nijmegan breakage syndrome. J Pediatr Hematol Oncol 27:239PubMedGoogle Scholar
  108. 108.
    Gennery AR, Slatter MA, Bredius RG, Hagleitner MM, Weemaes C, Cant AJ, Lankester AC (2007) Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency centromeric instability facial dysmorphism syndrome. Pediatrics 120:1341–1344Google Scholar
  109. 109.
    Gerdes M, Solot C, Wang PP, Moss E, LaRossa D, Randall P, Goldmuntz E, Clark BJ, 3rd, Driscoll DA, Jawad A, Emanuel BS, McDonald-McGinn DM, Batshaw ML, Zackai EH (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85:127–133PubMedGoogle Scholar
  110. 110.
    German J (1993) Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72:393–406Google Scholar
  111. 111.
    German J (1995) Bloom’s syndrome. Dermatol Clin 13:7–18PubMedGoogle Scholar
  112. 112.
    German J (1997) Bloom’s syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 93:100–106PubMedGoogle Scholar
  113. 113.
    German J, Ellis NA, Proytcheva M (1996) Bloom’s syndrome. XIX. Cytogenetic and population evidence for genetic heterogeneity. Clin Genet 49:223–231PubMedGoogle Scholar
  114. 114.
    Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, Jacobelli J, Bandiera E, Notarangelo L, Santoni A (2004) Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood 104:436–443PubMedGoogle Scholar
  115. 115.
    Glaser B, Debbane M, Hinard C, Morris MA, Dahoun SP, Antonarakis SE, Eliez S (2006) No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. Am J Psychiatry 163:537–539PubMedGoogle Scholar
  116. 116.
    Glass RB, Tifft CJ (1999) Radiologic changes in infancy in McKusick cartilage hair hypoplasia. Am J Med Genet 86:312–315PubMedGoogle Scholar
  117. 117.
    Godic A, Dragos V (2004) Successful treatment of Netherton’s syndrome with topical calcipotriol. Eur J Dermatol 14:115–117PubMedGoogle Scholar
  118. 118.
    Goldsobel AB, Haas A, Stiehm ER (1987) Bone marrow transplantation in DiGeorge syndrome. J Pediatr 111:40–44PubMedGoogle Scholar
  119. 119.
    Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM, Dugaw KA, Paddock MN, Parson WW (2001) Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 57:410–416PubMedGoogle Scholar
  120. 120.
    Greenberg F (1993) DiGeorge syndrome: an historical review of clinical and cytogenetic features. J Med Genet 30:803–806PubMedGoogle Scholar
  121. 121.
    Greenberg F, Elder FF, Haffner P, Northrup H, Ledbetter DH (1988) Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet 43:605–611PubMedGoogle Scholar
  122. 122.
    Greene SL, Muller SA (1985) Netherton’s syndrome. Report of a case and review of the literature. J Am Acad Dermatol 13:329–337PubMedGoogle Scholar
  123. 123.
    Gregorek H, Chrzanowska KH, Michalkiewicz J, Syczewska M, Madalinski K (2002) Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre. Clin Exp Immunol 130:319–324PubMedGoogle Scholar
  124. 124.
    Greider CW (1990) Telomeres, telomerase and senescence. Bioessays 12:363–369PubMedGoogle Scholar
  125. 125.
    Greider CW, Blackburn EH (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51:887–898PubMedGoogle Scholar
  126. 126.
    Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’Connell AC, Puck JM (1999) Hyper-IgE syndrome with recurrent infections – an autosomal dominant multisystem disorder. N Engl J Med 340:692–702PubMedGoogle Scholar
  127. 127.
    Grimbacher B, Holland SM, Puck JM (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250PubMedGoogle Scholar
  128. 128.
    Grimbacher B, Schaffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, Espanol T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs HD, Renner ED, Wellinghausen N, Puck JM (1999) Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 65:735–744PubMedGoogle Scholar
  129. 129.
    Grossman MH, Emanuel BS, Budarf ML (1992) Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 12:822–825PubMedGoogle Scholar
  130. 130.
    Grouhi M, Dalal I, Nisbet-Brown E, Roifman CM (1998) Cerebral vasculitis associated with chronic mucocutaneous candidiasis. J Pediatr 133:571–574PubMedGoogle Scholar
  131. 131.
    Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A (2001) Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27:293–298PubMedGoogle Scholar
  132. 132.
    Haddad E, Zugaza JL, Louache F, Debili N, Crouin C, Schwarz K, Fischer A, Vainchenker W, Bertoglio J (2001) The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood 97:33–38PubMedGoogle Scholar
  133. 133.
    Hagleitner M, Lankester A, Maraschio P, Hulten M, Fryns J, Schuetz C, Gimelli G, Davies E, Gennery A, Belohradsky B, de Groot R, Gerritsen E, Mattina T, Howard P, Fasth A, Reisli I, Furthner D, Slatter M, Cant A, Cazzola G, van Dijken P, van Deuren M, de Greef J, van der Maarel S, Weemaes C (2008) Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF-syndrome). J Med Genet 45:93–99PubMedGoogle Scholar
  134. 134.
    Halford S, Wadey R, Roberts C, Daw SC, Whiting JA, O’Donnell H, Dunham I, Bentley D, Lindsay E, Baldini A, et al. (1993) Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet 2:2099–2107PubMedGoogle Scholar
  135. 135.
    Hardy I, Gershon AA, Steinberg SP, LaRussa P (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325:1545–1550PubMedGoogle Scholar
  136. 136.
    Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460PubMedGoogle Scholar
  137. 137.
    Harrison CA, Layton CM, Hau Z, Bullock AJ, Johnson TS, MacNeil S (2007) Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin. Br J Dermatol 156:247–257PubMedGoogle Scholar
  138. 138.
    Hartschuh W, Hausser I, Petzoldt D (1989) Successful retinoid therapy of Netherton syndrome. Hautarzt 40:430–433PubMedGoogle Scholar
  139. 139.
    Hashimoto K, Takeuchi A, Ieshima A, Takada M, Kasagi M (1994) Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet 49:266–269PubMedGoogle Scholar
  140. 140.
    Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM (2002) Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347:26–34PubMedGoogle Scholar
  141. 141.
    Hausser I, nton-Lamprecht I, Hartschuh W, Petzoldt D (1989) Netherton’s syndrome: ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res 281:165–172PubMedGoogle Scholar
  142. 142.
    Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP (2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann Rev Immunol 18:529–560Google Scholar
  143. 143.
    Heiss NS, Poustka A, Knight SW, Aradhya S, Nelson DL, Lewis RA, Esposito T, Ciccodicola A, D’Urso M, Smahi A, Heuertz S, Munnich A, Vabres P, Woffendin H, Kenwrick S (1999) Mutation analysis of the DKC1 gene in incontinentia pigmenti. J Med Genet 36:860–862PubMedGoogle Scholar
  144. 144.
    Hernandez D, McConville CM, Stacey M, Woods CG, Brown MM, Shutt P, Rysiecki G, Taylor AM (1993) A family showing no evidence of linkage between the ataxia-telangiectasia gene and chromosome 11q22–23. J Med Genet 30:135–140PubMedGoogle Scholar
  145. 145.
    Herrod HG (1990) Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. J Pediatr 116:377–382PubMedGoogle Scholar
  146. 146.
    Hickson ID (2003) RecQ helicases: caretakers of the genome. Nat Rev Cancer 3:169–178PubMedGoogle Scholar
  147. 147.
    Hoger PH, Boltshauser E, Hitzig WH (1985) Craniosynostosis in hyper-IgE-syndrome. Eur J Pediatr 144:414–417PubMedGoogle Scholar
  148. 148.
    Holland SM, Deleo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schaffer AA, Puck JM, Grimbacher B (2007) STAT3 Mutations in the Hyper-IgE Syndrome. N Engl J Med 357:1608–1619PubMedGoogle Scholar
  149. 149.
    Honig M, Schwarz K (2006) Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol 18:383–388PubMedGoogle Scholar
  150. 150.
    Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM (1999) Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation. Br J Dermatol 141:453–459PubMedGoogle Scholar
  151. 151.
    Hoyeraal HM, Lamvik J, Moe PJ (1970) Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatr Scand 59:185–191PubMedGoogle Scholar
  152. 152.
    Hreidarsson S, Kristjansson K, Johannesson G, Johannsson JH (1988) A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand 77:773–775PubMedGoogle Scholar
  153. 153.
    Huo YK, Wang Z, Hong JH, Chessa L, McBride WH, Perlman SL, Gatti RA (1994) Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res 54:2544–2547PubMedGoogle Scholar
  154. 154.
    Ishida-Yamamoto A, Deraison C, Bonnart C, Bitoun E, Robinson R, O’Brien TJ, Wakamatsu K, Ohtsubo S, Takahashi H, Hashimoto Y, Dopping-Hepenstal PJ, McGrath JA, Iizuka H, Richard G, Hovnanian A (2005) LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol 124:360–366PubMedGoogle Scholar
  155. 155.
    Ivker RA, Woosley J, Resnick SD (1993) Dyskeratosis congenita or chronic graft-versus-host disease? A diagnostic dilemma in a child eight years after bone marrow transplantation for aplastic anemia. Pediatr Dermatol 10:362–365PubMedGoogle Scholar
  156. 156.
    Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE (2001) Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 139:715–723PubMedGoogle Scholar
  157. 157.
    Judge MR, Morgan G, Harper JI (1994) A clinical and immunological study of Netherton’s syndrome. Br J Dermatol 131:615–621PubMedGoogle Scholar
  158. 158.
    Kaitila I, Savilahti E, Ormala T (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia. Am J Med Genet 77:427–430PubMedGoogle Scholar
  159. 159.
    Kalfa VC, Roberts RL, Stiehm ER (2003) The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann Allergy Asthma Immunol 90:259–264PubMedCrossRefGoogle Scholar
  160. 160.
    Kaneko H, Kondo N (2004) Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. Expert Rev Mol Diagn 4:393–401PubMedGoogle Scholar
  161. 161.
    Kasprzak L, Der Kaloustian VM, Elliott AM, Shevell M, Lejtenyi C, Eydoux P (1998) Deletion of 22q11 in two brothers with different phenotype. Am J Med Genet 75:288–291PubMedGoogle Scholar
  162. 162.
    Kawai S, Minegishi M, Ohashi Y, Sasahara Y, Kumaki S, Konno T, Miki H, Derry J, Nonoyama S, Miyawaki T, Horibe K, Tachibana N, Kudoh E, Yoshimura Y, Izumikawa Y, Sako M, Tsuchiya S (2002) Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 260:195–205PubMedGoogle Scholar
  163. 163.
    Kelley RI, Zackai EH, Emanuel BS, Kistenmacher M, Greenberg F, Punnett HH (1982) The association of the DiGeorge anomalad with partial monosomy of chromosome 22. J Pediatr 101:197–200PubMedGoogle Scholar
  164. 164.
    Kennedy RD, D’Andrea AD (2006) DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 24:3799–3808PubMedGoogle Scholar
  165. 165.
    Kilic SS, Donmez O, Sloan EA, Elizondo LI, Huang C, Andre JL, Bogdanovic R, Cockfield S, Cordeiro I, Deschenes G, Frund S, Kaitila I, Lama G, Lamfers P, Lucke T, Milford DV, Najera L, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Stajic N, Stein A, Taha D, Wand D, Armstrong D, Boerkoel CF (2005) Association of migraine-like headaches with Schimke immuno-osseous dysplasia. Am J Med Genet A 135:206–210PubMedGoogle Scholar
  166. 166.
    Kilic SS, Kilicbay F (2006) Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome. Pediatrics 117:e1253–e1255PubMedGoogle Scholar
  167. 167.
    King CL, Gallin JI, Malech HL, Abramson SL, Nutman TB (1989) Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci USA 86:10085–10089PubMedGoogle Scholar
  168. 168.
    Kirby ML, Bockman DE (1984) Neural crest and normal development: a new perspective. Anat Rec 209:1–6PubMedGoogle Scholar
  169. 169.
    Kirkpatrick CH (2001) Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 20:197–206PubMedGoogle Scholar
  170. 170.
    Kirkpatrick CH, Windhorst DB (1979) Mucocutaneous candidiasis and thymoma. Am J Med 66:939–945PubMedGoogle Scholar
  171. 171.
    Klein C, Nguyen D, Liu CH, Mizoguchi A, Bhan AK, Miki H, Takenawa T, Rosen FS, Alt FW, Mulligan RC, Snapper SB (2003) Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101:2159–2166PubMedGoogle Scholar
  172. 172.
    Klein C, Wenning GK, Quinn NP, Marsden CD (1996) Ataxia without telangiectasia masquerading as benign hereditary chorea. Mov Disord 11:217–220PubMedGoogle Scholar
  173. 173.
    Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, Jones A, Hennekam RC, Poustka A, Mason PJ, Dokal I (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107:335–339PubMedGoogle Scholar
  174. 174.
    Knudson M, Kulkarni S, Ballas ZK, Bessler M, Goldman F (2005) Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood 105:682–688PubMedGoogle Scholar
  175. 175.
    Konno A, Wada T, Schurman SH, Garabedian EK, Kirby M, Anderson SM, Candotti F (2004) Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood 103:676–678PubMedGoogle Scholar
  176. 176.
    Kornblut AD (1980) An evolution of therapy for mucocutaneous candidiasis. Laryngoscope 90:1–30PubMedGoogle Scholar
  177. 177.
    Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74:681–710PubMedGoogle Scholar
  178. 178.
    Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF (1996) Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67:468–472PubMedGoogle Scholar
  179. 179.
    Lammer EJ, Opitz JM (1986) The DiGeorge anomaly as a developmental field defect. Am J Med Genet Suppl 2:113–127PubMedGoogle Scholar
  180. 180.
    Langston AA, Sanders JE, Deeg HJ, Crawford SW, Anasetti C, Sullivan KM, Flowers ME, Storb R (1996) Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 92:758–765PubMedGoogle Scholar
  181. 181.
    Leana-Cox J, Pangkanon S, Eanet KR, Curtin MS, Wulfsberg EA (1996) Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature. Am J Med Genet 65:309–316PubMedGoogle Scholar
  182. 182.
    Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, Wilson WH (2004) Non-Hodgkin’s lymphoma in Job’s syndrome: a case report and literature review. Leuk Lymphoma 45:2521–2525PubMedGoogle Scholar
  183. 183.
    Levy A, Michel G, Lemerrer M, Philip N (1997) Idiopathic thrombocytopenic purpura in two mothers of children with DiGeorge sequence: a new component manifestation of deletion 22q11? Am J Med Genet 69:356–359PubMedGoogle Scholar
  184. 184.
    Lilic D (2002) New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis 15:143–147PubMedGoogle Scholar
  185. 185.
    Lin SP, Huang SY, Tu ME, Wu YH, Lin CY, Lin HY, Lee-Chen GJ (2007) Netherton syndrome: mutation analysis of two Taiwanese families. Arch Dermatol Res 299:145–150PubMedGoogle Scholar
  186. 186.
    Linder S, Nelson D, Weiss M, Aepfelbacher M (1999) Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A 96:9648–9653PubMedGoogle Scholar
  187. 187.
    Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah YC, Rosenblatt HM, Bradley A, Baldini A (1999) Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379–383PubMedGoogle Scholar
  188. 188.
    Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, Holland SM (2007) Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 122:255–258PubMedGoogle Scholar
  189. 189.
    Lischner HW, Huff DS (1975) T-cell deficiency in diGeorge syndrome. Birth Defects Orig Artic Ser 11:16–21PubMedGoogle Scholar
  190. 190.
    Litzman J, Jones A, Hann I, Chapel H, Strobel S, Morgan G (1996) Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child 75:436–439PubMedGoogle Scholar
  191. 191.
    Loeys BL, Van Coster RN, Defreyne LR, Leroy JG (1999) Fungal intracranial aneurysm in a child with familial chronic mucocutaneous candidiasis. Eur J Pediatr 158:650–652PubMedGoogle Scholar
  192. 192.
    Lou S, Lamfers P, McGuire N, Boerkoel CF (2002) Longevity in Schimke immuno-osseous dysplasia. J Med Genet 39:922–925PubMedGoogle Scholar
  193. 193.
    Ludman MD, Cole DE, Crocker JF, Cohen MM, Jr. (1993) Schimke immuno-osseous dysplasia: case report and review. Am J Med Genet 47:793–796PubMedGoogle Scholar
  194. 194.
    Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst) 3:997–1007Google Scholar
  195. 195.
    Luo G, Yao MS, Bender CF, Mills M, Bladl AR, Bradley A, Petrini JH (1999) Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A 96:7376–7381PubMedGoogle Scholar
  196. 196.
    Lutskiy MI, Beardsley DS, Rosen FS, Remold-O’Donnell E (2005) Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood 106:2815–2817PubMedGoogle Scholar
  197. 197.
    Ma Y, Lu H, Schwarz K, Lieber MR (2005) Repair of double-strand DNA breaks by the human nonhomologous DNA end joining pathway: the iterative processing model. Cell Cycle 4:1193–1200PubMedGoogle Scholar
  198. 198.
    Ma Y, Schwarz K, Lieber MR (2005) The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair (Amst) 4:845–851Google Scholar
  199. 199.
    Magert HJ, Standker L, Kreutzmann P, Zucht HD, Reinecke M, Sommerhoff CP, Fritz H, Forssmann WG (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 274:21499–21502PubMedGoogle Scholar
  200. 200.
    Makitie O, Kaitila I (1993) Cartilage-hair hypoplasia – clinical manifestations in 108 Finnish patients. Eur J Pediatr 152:211–217PubMedGoogle Scholar
  201. 201.
    Makitie O, Kaitila I, Savilahti E (1998) Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr 157:816–820PubMedGoogle Scholar
  202. 202.
    Makitie O, Kaitila I, Savilahti E (2000) Deficiency of humoral immunity in cartilage-hair hypoplasia. J Pediatr 137:487–492PubMedGoogle Scholar
  203. 203.
    Makitie O, Marttinen E, Kaitila I (1992) Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients. Pediatr Radiol 22:434–439PubMedGoogle Scholar
  204. 204.
    Makitie O, Perheentupa J, Kaitila I (1992) Growth in cartilage-hair hypoplasia. Pediatr Res 31:176–180PubMedGoogle Scholar
  205. 205.
    Makitie O, Pukkala E, Teppo L, Kaitila I (1999) Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr 134:315–318PubMedGoogle Scholar
  206. 206.
    Mangino M, Salpietro DC, Zuccarello D, Gangemi S, Rigoli L, Merlino MV, Briuglia S, Bisignano G, Mingarelli R, Dallapiccola B (2003) A gene for familial isolated chronic nail candidiasis maps to chromosome 11p12–q12.1. Eur J Hum Genet 11:433–436PubMedGoogle Scholar
  207. 207.
    Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo LD, Baz Z, Metin A, Cattaneo F, Villa A, Aiuti A, Battaglia M, Roncarolo MG, Dupre L (2007) WASP regulates suppressor activity of human and murine CD4(+) CD25(+) FOXP3(+) natural regulatory T cells. J Exp Med 204:369–380PubMedGoogle Scholar
  208. 208.
    Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L (1988) Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 25:173–180PubMedGoogle Scholar
  209. 209.
    Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Vogel M, Versmold H (2000) Fatal aspergillosis with brain abscesses in a neonate with DiGeorge syndrome. Pediatr Infec Dis J 19:1214–1216Google Scholar
  210. 210.
    Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sempowski GD, Rhein ME, Szabolcs P, Hale LP, Buckley RH, Coyne KE, Rice HE, Mahaffey SM, Skinner MA (2004) Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 113:734–741PubMedGoogle Scholar
  211. 211.
    Markert ML, Devlin BH, Alexieff MJ, Li J, McCarthy EA, Gupton SE, Chinn IK, Hale LP, Kepler TB, He M, Sarzotti M, Skinner MA, Rice HE, Hoehner JC (2007) Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 109:4539–4547PubMedGoogle Scholar
  212. 212.
    Markert ML, Sarzotti M, Ozaki DA, Sempowski GD, Rhein ME, Hale LP, Le Deist F, Alexieff MJ, Li J, Hauser ER, Haynes BF, Rice HE, Skinner MA, Mahaffey SM, Jaggers J, Stein LD, Mill MR (2003) Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 102:1121–1130PubMedGoogle Scholar
  213. 213.
    Marrone A, Walne A, Tamary H, Masunari Y, Kirwan M, Beswick R, Vulliamy T, Dokal I (2007) Telomerase reverse transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood 110:4198–4205PubMedGoogle Scholar
  214. 214.
    Martin F, Toscano MG, Blundell M, Frecha C, Srivastava GK, Santamaria M, Thrasher AJ, Molina IJ (2005) Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences. Gene Ther 12:715–723PubMedGoogle Scholar
  215. 215.
    Matsumoto T, Amamoto N, Kondoh T, Nakayama M, Takayanagi T, Tsuji Y (1998) Complete-type DiGeorge syndrome treated by bone marrow transplantation. Bone Marrow Transplant 22:927–930PubMedGoogle Scholar
  216. 216.
    Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, Endo S, Smeets D, Solder B, Belohradsky BH, Der KV, Oshimura M, Isomura M, Nakamura Y, Komatsu K (1998) Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet 19:179–181PubMedGoogle Scholar
  217. 217.
    Mayumi M, Kimata H, Suehiro Y, Hosoi S, Ito S, Kuge Y, Shinomiya K, Mikawa H (1989) DiGeorge syndrome with hypogammaglobulinemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr 148:518–522PubMedGoogle Scholar
  218. 218.
    McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heher K, Wilson M, Ming JE, Grace K, Driscoll D, Pasquariello P, Randall P, Larossa D, Emanuel BS, Zackai EH (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10:11–24PubMedGoogle Scholar
  219. 219.
    McKusick VA, Eldridge R, Hostetler JA, Ruangwit U, Egeland JA, Dwarfism. In: Amish Ii (1965) Cartilage-Hair Hypoplasia. Bull Johns Hopkins Hosp 116:285–326PubMedGoogle Scholar
  220. 220.
    McLean-Tooke A, Spickett GP, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66:1–7PubMedGoogle Scholar
  221. 221.
    Miki H, Miura K, Takenawa T (1996) N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J 15:5326–5335PubMedGoogle Scholar
  222. 222.
    Miki H, Nonoyama S, Zhu Q, Aruffo A, Ochs HD, Takenawa T (1997) Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. Cell Growth Differ 8:195–202PubMedGoogle Scholar
  223. 223.
    Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25:745–755PubMedGoogle Scholar
  224. 224.
    Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058–1062PubMedGoogle Scholar
  225. 225.
    Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551–555PubMedGoogle Scholar
  226. 226.
    Mitnick RJ, Bello JA, Shprintzen RJ (1994) Brain anomalies in velo-cardio-facial syndrome. Am J Med Genet 54:100–106PubMedGoogle Scholar
  227. 227.
    Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, Gharagozlou M, Mirsaeid Ghazi B, Arshi S, Mansouri D, Sherkat R, Kashef S, Mahmoudi M, Nabavi M, Aghamohammadi A (2006) The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome. Scand J Infect Dis 38:898–903PubMedGoogle Scholar
  228. 228.
    Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O’Donnell E (1993) T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol 151:4383–4390PubMedGoogle Scholar
  229. 229.
    Muller W, Peter HH, Wilken M, Juppner H, Kallfelz HC, Krohn HP, Miller K, Rieger CH (1988) The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 147:496–502PubMedGoogle Scholar
  230. 230.
    Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398PubMedGoogle Scholar
  231. 231.
    Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR (1998) Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med 105:162–164PubMedGoogle Scholar
  232. 232.
    Netherton EW (1958) A unique case of trichorrhexis nodosa: “bamboo hairs”. AMA Arch Derm 78:483–487PubMedGoogle Scholar
  233. 233.
    Nobes CD, Hall A (1995) Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23:456–459PubMedGoogle Scholar
  234. 234.
    North J, Kotecha S, Houtman P, Whaley K (1997) Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol 36:297–298PubMedGoogle Scholar
  235. 235.
    Notarangelo LD, Mazza C, Forino C, Mazzolari E, Buzi F (2004) AIRE and immunological tolerance: insights from the study of autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy. Curr Opin Allergy Clin Immunol 4:491–496PubMedGoogle Scholar
  236. 236.
    Notarangelo LD, Mazza C, Giliani S, D’Aria C, Gandellini F, Ravelli C, Locatelli MG, Nelson DL, Ochs HD, Notarangelo LD (2002) Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood 99:2268–2269PubMedGoogle Scholar
  237. 237.
    Notarangelo LD, Mori L (2005) Wiskott-Aldrich syndrome: another piece in the puzzle. Clin Exp Immunol 139:173–175PubMedGoogle Scholar
  238. 238.
    O’Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin JI, Malech HL, Holland SM (2000) Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:177–185PubMedGoogle Scholar
  239. 239.
    O’Driscoll M, Jeggo PA (2006) The role of double-strand break repair – insights from human genetics. Nat Rev Genet 7:45–54PubMedGoogle Scholar
  240. 240.
    Ochs HD (2002) The Wiskott-Aldrich syndrome. Isr Med Assoc J 4:379–384PubMedGoogle Scholar
  241. 241.
    Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ (1980) The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 55:243–252PubMedGoogle Scholar
  242. 242.
    Ochs HD, Thrasher AJ (2006) The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117:725–738; quiz 739PubMedGoogle Scholar
  243. 243.
    Okamoto GA, Hall JG, Ochs H, Jackson C, Rodaway K, Chandler J (1977) New syndrome of chronic mucocutaneous candidiasis. Birth Defects Orig Artic Ser 13:117–125PubMedGoogle Scholar
  244. 244.
    Orange JS, Ramesh N, Remold-O’Donnell E, Sasahara Y, Koopman L, Byrne M, Bonilla FA, Rosen FS, Geha RS, Strominger JL (2002) Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci USA 99:11351–11356PubMedGoogle Scholar
  245. 245.
    Orange JS, Stone KD, Turvey SE, Krzewski K (2004) The Wiskott-Aldrich syndrome. Cell Mol Life Sci 61:2361–2385PubMedGoogle Scholar
  246. 246.
    Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kuhlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Luthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12:401–409PubMedGoogle Scholar
  247. 247.
    Palestine RF, Su WP, Liesegang TJ (1983) Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma. Arch Dermatol 119:580–586PubMedGoogle Scholar
  248. 248.
    Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O’Donnell E (2004) Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol 136:104–110PubMedGoogle Scholar
  249. 249.
    Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O’Donnell E (2005) Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol 139:297–305PubMedGoogle Scholar
  250. 250.
    Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886–895PubMedGoogle Scholar
  251. 251.
    Perlman S, Becker-Catania S, Gatti RA (2003) Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 10:173–182PubMedGoogle Scholar
  252. 252.
    Peron S, Pan-Hammarstrom Q, Imai K, Du L, Taubenheim N, Sanal O, Marodi L, Bergelin-Besancon A, Benkerrou M, de Villartay JP, Fischer A, Revy P, Durandy A (2007) A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair. J Exp Med 204:1207–1216PubMedGoogle Scholar
  253. 253.
    Petrini JH, Stracker TH (2003) The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13:458–462PubMedGoogle Scholar
  254. 254.
    Petty EM, Yanik GA, Hutchinson RJ, Alter BP, Schmalstieg FC, Levine JE, Ginsburg D, Robillard JE, Castle VP (2000) Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia. J Pediatr 137:882–886PubMedGoogle Scholar
  255. 255.
    Pezzolo A, Prigione I, Facchetti P, Castellano E, Viale M, Gimelli G, Pistoia V (2001) T-cell apoptosis in ICF syndrome. J Allergy Clin Immunol 108:310–312PubMedGoogle Scholar
  256. 256.
    Phillips RJ, Judge M, Webb D, Harper JI (1992) Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation. Br J Dermatol 127:278–280PubMedGoogle Scholar
  257. 257.
    Pitts SA, Kullar HS, Stankovic T, Stewart GS, Last JI, Bedenham T, Armstrong SJ, Piane M, Chessa L, Taylor AM, Byrd PJ (2001) hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum Mol Genet 10:1155–1162PubMedGoogle Scholar
  258. 258.
    Polmar SH, Pierce GF (1986) Cartilage hair hypoplasia: immunological aspects and their clinical implications. Clin Immunol Immunopathol 40:87–93PubMedGoogle Scholar
  259. 259.
    Regueiro JR, Porras O, Lavin M, Gatti RA (2000) Ataxia-telangiectasia:A primary immunodeficiency revisited. Immunol Allergy Clin North Am 20:177–206Google Scholar
  260. 260.
    Rengan R, Ochs HD, Sweet LI, Keil ML, Gunning WT, Lachant NA, Boxer LA, Omann GM (2000) Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood 95:1283–1292PubMedGoogle Scholar
  261. 261.
    Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99PubMedGoogle Scholar
  262. 262.
    Revy P, Malivert L, de Villartay JP (2006) Cernunnos-XLF, a recently identified non-homologous end-joining factor required for the development of the immune system. Curr Opin Allergy Clin Immunol 6:416–420PubMedGoogle Scholar
  263. 263.
    Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, Parker AR, Jackson SP, Gennery A, Jeggo PA, Lobrich M (2004) A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell 16:715–724PubMedGoogle Scholar
  264. 264.
    Ridanpaa M, van Eenennaam H, Pelin K, Chadwick R, Johnson C, Yuan B, vanVenrooij W, Pruijn G, Salmela R, Rockas S, Makitie O, Kaitila I, de la Chapelle A (2001) Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104:195–203PubMedGoogle Scholar
  265. 265.
    Rose C, Kern WV (1992) Another case of Pneumocystis carinii pneumonia in a patient with dyskeratosis congenita (Zinsser-Cole-Engman syndrome). Clin Infect Dis 15:1056–1057PubMedGoogle Scholar
  266. 266.
    Rothberg MS, Eisenbud L, Griboff S (1989) Chronic mucocutaneous candidiasis-thymoma syndrome. A case report. Oral Surg Oral Med Oral Pathol 68:411–413PubMedGoogle Scholar
  267. 267.
    Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259–262PubMedGoogle Scholar
  268. 268.
    Russo CL, Glader BE, Israel RJ, Galasso F (1990) Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Lancet 336:751–752PubMedGoogle Scholar
  269. 269.
    Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K, Scambler PJ, et al. (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804PubMedGoogle Scholar
  270. 270.
    Saif GB, Al-Khenaizan S (2007) Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings. Int J Dermatol 46:290–294PubMedGoogle Scholar
  271. 271.
    Sanal O, Ersoy F, Yel L, Tezcan I, Metin A, Ozyurek H, Gariboglu S, Fikrig S, Berkel AI, Rijkers GT, Zegers BJ (1999) Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia- telangiectasia. J Clin Immunol 19:326–334PubMedGoogle Scholar
  272. 272.
    Sanchez-Velasco P, Ocejo-Vinyals JG, Flores R, Gomez-Roman JJ, Lozano MJ, Leyva-Cobian F (2001) Simultaneous multiorgan presence of human herpesvirus 8 and restricted lymphotropism of Epstein-Barr virus DNA sequences in a human immunodeficiency virus-negative immunodeficient infant. J Infect Dis 183:338–342PubMedGoogle Scholar
  273. 273.
    Santava A, Zapletalova J, Michalkova K, Hanakova S, Kopriva F, Santavy J, Dusek J, Kleinova D (1994) Spondyloepiphyseal dysplasia with nephrotic syndrome (Schimke immunoosseous dysplasia). Am J Med Genet 49:270–273PubMedGoogle Scholar
  274. 274.
    Saraiva JM, Dinis A, Resende C, Faria E, Gomes C, Correia AJ, Gil J, da Fonseca N (1999) Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet 36:786–789PubMedGoogle Scholar
  275. 275.
    Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, Geha RS (2002) Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 10:1269–1281PubMedGoogle Scholar
  276. 276.
    Schatz DG, Spanopoulou E (2005) Biochemistry of V(D) J recombination. Curr Top Microbiol Immunol 290:49–85PubMedGoogle Scholar
  277. 277.
    Schimke RN, Horton WA, King CR, Martin NL (1974) Chondroitin-6-sulfate mucopolysaccharidosis in conjunction with lymphopenia, defective cellular immunity and the nephrotic syndrome. Birth Defects Orig Artic Ser 10:258–266PubMedGoogle Scholar
  278. 278.
    Shaikh TH, Kurahashi H, Saitta SC, O’Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM, Zackai EH, Budarf ML, Emanuel BS (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489–501PubMedGoogle Scholar
  279. 279.
    Shashi V, Keshavan MS, Howard TD, Berry MN, Basehore MJ, Lewandowski E, Kwapil TR (2006) Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet 69:234–238PubMedGoogle Scholar
  280. 280.
    Shiloh Y (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 31:635–662PubMedGoogle Scholar
  281. 281.
    Smith DL, Smith JG, Wong SW, deShazo RD (1995) Netherton’s syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95:116–123PubMedGoogle Scholar
  282. 282.
    Snapper SB, Rosen FS (2003) A family of WASPs. N Engl J Med 348:350–351PubMedGoogle Scholar
  283. 283.
    Sousa MD, Cochran R, Mackie R, Parratt D, rala-Chaves M (1976) Chronic mucocutaneous candidiasis treated with transfer factor. Br J Dermatol 94:79–83PubMedGoogle Scholar
  284. 284.
    Sperling K, Seemanova E, Varon R, Jarolim P, Pelz J (2002) Cancer risk in NBS heterozygotes from the Czech Republic. Am J Hum Genet 71:238Google Scholar
  285. 285.
    Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 119:64–72PubMedGoogle Scholar
  286. 286.
    Sprecher E, Chavanas S, DiGiovanna JJ, Amin S, Nielsen K, Prendiville JS, Silverman R, Esterly NB, Spraker MK, Guelig E, de Luna ML, Williams ML, Buehler B, Siegfried EC, Van ML, Pfendner E, Bale SJ, Uitto J, Hovnanian A, Richard G (2001) The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 117:179–187PubMedGoogle Scholar
  287. 287.
    Staple L, Andrews T, McDonald-McGinn D, Zackai E, Sullivan KE (2005) Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr Allergy Immunol 16:226–230PubMedGoogle Scholar
  288. 288.
    Stewart GS, Stankovic T, Byrd PJ, Wechsler T, Miller ES, Huissoon A, Drayson MT, West SC, Elledge SJ, Taylor AM (2007) RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci USA 104: 16910–16915PubMedGoogle Scholar
  289. 289.
    Stiff T, O’Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA (2004) ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64:2390–2396PubMedGoogle Scholar
  290. 290.
    Storman M, Friedman J, King S, Cutz E, Furuya KN (2002) An unusual case of diarrhea in Schimke immuno-osseous dysplasia. J Pediatr Gastroenterol Nutr 35:369–371Google Scholar
  291. 291.
    Strom TS, Gabbard W, Kelly PF, Cunningham JM, Nienhuis AW (2003) Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther 10:803–809PubMedGoogle Scholar
  292. 292.
    Strom TS, Turner SJ, Andreansky S, Liu H, Doherty PC, Srivastava DK, Cunningham JM, Nienhuis AW (2003) Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102:3108–3116PubMedGoogle Scholar
  293. 293.
    Stryk S, Siegfried EC, Knutsen AP (1999) Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Pediatr Dermatol 16:19–22PubMedGoogle Scholar
  294. 294.
    Suga Y, Tsuboi R, Hashimoto Y, Yoshiike T, Ogawa H (2000) A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. J Am Acad Dermatol 42:520–522PubMedGoogle Scholar
  295. 295.
    Sulisalo T, Sistonen P, Hastbacka J, Wadelius C, Makitie O, de la Chapelle A, Kaitila I (1993) Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nat Genet 3:338–341PubMedGoogle Scholar
  296. 296.
    Sullivan KE, McDonald-McGinn D, Zackai EH (2002) CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunology 9:1129–1131Google Scholar
  297. 297.
    Sullivan KE, McDonald-McGinn DM, Driscoll DA, Zmijewski CM, Ellabban AS, Reed L, Emanuel BS, Zackai EH, Athreya BH, Keenan G (1997) Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arth Rheumat 40:430–436Google Scholar
  298. 298.
    Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885PubMedGoogle Scholar
  299. 299.
    Sun X, Becker-Catania SG, Chun HH, Hwang MJ, Huo Y, Wang Z, Mitui M, Sanal O, Chessa L, Crandall B, Gatti RA (2002) Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. J Pediatr 140:724–731PubMedGoogle Scholar
  300. 300.
    Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, Fryns JP (1999) The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 10:79–88PubMedGoogle Scholar
  301. 301.
    Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A (1996) Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723–734PubMedGoogle Scholar
  302. 302.
    Sznajer Y, Baumann C, David A, Journel H, Lacombe D, Perel Y, Blouin P, Segura JF, Cezard JP, Peuchmaur M, Vulliamy T, Dokal I, Verloes A (2003) Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr 162:863–867PubMedGoogle Scholar
  303. 303.
    Takenawa T, Miki H (2001) WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci 114:1801–1809PubMedGoogle Scholar
  304. 304.
    Takenawa T, Suetsugu S (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev 8:37–48Google Scholar
  305. 305.
    Taylor AM, Groom A, Byrd PJ (2004) Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst) 3:1219–1225Google Scholar
  306. 306.
    Thiel CT, Horn D, Zabel B, Ekici AB, Salinas K, Gebhart E, Ruschendorf F, Sticht H, Spranger J, Muller D, Zweier C, Schmitt ME, Reis A, Rauch A (2005) Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet 77:795–806PubMedGoogle Scholar
  307. 307.
    Thoms KM, Kuschal C, Emmert S (2007) Lessons learned from DNA repair defective syndromes. Exp Dermatol 16:532–544PubMedGoogle Scholar
  308. 308.
    Thong YH, Robertson EF, Rischbieth HG, Smith GJ, Binns GF, Cheney K, Pollard AC (1978) Successful restoration of immunity in the DiGeorge syndrome with fetal thymic epithelial transplant. Arch Dis Child 53:580–584PubMedGoogle Scholar
  309. 309.
    Thorpe ES, Handley HE (1929) Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years. Am J Dis 38:228–238Google Scholar
  310. 310.
    Thrasher AJ, Jones GE, Kinnon C, Brickell PM, Katz DR (1998) Is Wiskott – Aldrich syndrome a cell trafficking disorder? Immunol Today 19:537–539PubMedGoogle Scholar
  311. 311.
    Tiepolo L, Maraschio P, Gimelli G, Cuoco C, Gargani GF, Romano C (1979) Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum Genet 51:127–137PubMedGoogle Scholar
  312. 312.
    Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M (2000) DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89:121–128PubMedGoogle Scholar
  313. 313.
    Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y (2003) Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22:5612–5621PubMedGoogle Scholar
  314. 314.
    Valkova G, Ghenev E, Tzancheva M (1987) Centromeric instability of chromosomes 1, 9 and 16 with variable immune deficiency. Support of a new syndrome. Clin Genet 31:119–124PubMedCrossRefGoogle Scholar
  315. 315.
    van der Burgt I, Chrzanowska KH, Smeets D, Weemaes C (1996) Nijmegen breakage syndrome. J Med Genet 33:153–156PubMedGoogle Scholar
  316. 316.
    van der Graaf CA, Netea MG, Drenth IP, te Morsche RH, van der Meer JW, Kullberg BJ (2003) Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth J Med 61:365–369PubMedGoogle Scholar
  317. 317.
    van Engelen BG, Hiel JA, Gabreels FJ, van den Heuvel LP, van GDC, Weemaes CM (2001) Decreased immunoglobulin class switching in Nijmegen Breakage syndrome due to the DNA repair defect. Hum Immunol 62:1324–1327PubMedGoogle Scholar
  318. 318.
    Vantrappen G, Devriendt K, Swillen A, Rommel N, Vogels A, Eyskens B, Gewillig M, Feenstra L, Fryns JP (1999) Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet Couns 10:3–9PubMedGoogle Scholar
  319. 319.
    Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93:467–476PubMedGoogle Scholar
  320. 320.
    Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG, et al. (1995) X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9:414–417PubMedGoogle Scholar
  321. 321.
    Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA (2002) Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111:565–576PubMedGoogle Scholar
  322. 322.
    Vulliamy T, Marrone A, Dokal I, Mason PJ (2002) Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359:2168–2170PubMedGoogle Scholar
  323. 323.
    Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432–435PubMedGoogle Scholar
  324. 324.
    Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447–449PubMedGoogle Scholar
  325. 325.
    Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I (2005) Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 34:257–263PubMedGoogle Scholar
  326. 326.
    Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, Nelson DL, Candotti F (2003) Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Investig 111:1389–1397PubMedGoogle Scholar
  327. 327.
    Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL, Candotti F (2001) Somatic mosaicism in Wiskott – Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A 98:8697–8702PubMedGoogle Scholar
  328. 328.
    Wahl GM, Carr AM (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 3:E277–E286PubMedGoogle Scholar
  329. 329.
    Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153–158PubMedCrossRefGoogle Scholar
  330. 330.
    Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, Masunari Y, Al-Qurashi FH, Aljurf M, Dokal I (2007) Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 16:1619–1629PubMedGoogle Scholar
  331. 331.
    Wang H, Wang H, Powell SN, Iliakis G, Wang Y (2004) ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining. Cancer Res 64:7139–7143PubMedGoogle Scholar
  332. 332.
    Webster WS, Ritchie HE (1991) Teratogenic effects of alcohol and isotretinoin on craniofacial development: an analysis of animal models. J Craniofacial Genet Dev Biol 11:296–302Google Scholar
  333. 333.
    Weemaes CM, Hustinx TW, Scheres JM, van Munster PJ, Bakkeren JA, Taalman RD (1981) A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand 70:557–564PubMedGoogle Scholar
  334. 334.
    Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH (1995) Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 85:2471–2477PubMedGoogle Scholar
  335. 335.
    Wiedemann HP, McGuire J, Dwyer JM, Sabetta J, Gee JB, Smith GJ, Loke J (1984) Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Arch Intern Med 144:397–399PubMedGoogle Scholar
  336. 336.
    Wilkinson RD, Curtis GH, Hawk WA (1964) Netherton’s disease; Trichorrehexis invaginata (Bamboo hair), congenital ichthyosiform erythroderma and the atopic diathesis. A histopathology study. Arch Dermatol 89:46–54PubMedGoogle Scholar
  337. 337.
    Williams MS, Ettinger RS, Hermanns P, Lee B, Carlsson G, Taskinen M, Makitie O (2005) The natural history of severe anemia in cartilage-hair hypoplasia. Am J Med Genet A 138:35–40PubMedGoogle Scholar
  338. 338.
    Woellner C, Schaffer AA, Puck JM, Renner ED, Knebel C, Holland SM, Plebani A, Grimbacher B (2007) The Hyper IgE Syndrome and Mutations in TYK2. Immunity 26:535PubMedGoogle Scholar
  339. 339.
    Wolach B, Eliakim A, Pomeranz A, Cohen AH, Nusbacher J, Metzker A (1996) Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 347:67PubMedGoogle Scholar
  340. 340.
    Wood MJ (1994) Current experience with antiviral therapy for acute herpes zoster. Ann Neurol 35 Suppl:S65–S68PubMedGoogle Scholar
  341. 341.
    Xiao Y, Weaver DT (1997) Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res 25:2985–2991PubMedGoogle Scholar
  342. 342.
    Yaghmai R, Kimyai-Asadi A, Rostamiani K, Heiss NS, Poustka A, Eyaid W, Bodurtha J, Nousari HC, Hamosh A, Metzenberg A (2000) Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr 136:390–393PubMedGoogle Scholar
  343. 343.
    Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366–1373PubMedGoogle Scholar
  344. 344.
    Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, Sloand E, Young NS (2003) Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102:916–918PubMedGoogle Scholar
  345. 345.
    Yamazaki-Nakashimada M, Zaltzman-Girshevich S, Garcia de la Puente S, De Leon-Bojorge B, Espinosa-Padilla S, Saez-de-Ocariz M, Carrasco-Daza D, Hernandez-Bautista V, Perez-Fernandez L, Espinosa-Rosales F (2006) Hyper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol 21:1200–1205PubMedGoogle Scholar
  346. 346.
    Young BR, Painter RB (1989) Radioresistant DNA synthesis and human genetic diseases. Hum Genet 82:113–117PubMedGoogle Scholar
  347. 347.
    Zhang J, Shehabeldin A, da Cruz LA, Butler J, Somani AK, McGavin M, Kozieradzki I, dos Santos AO, Nagy A, Grinstein S, Penninger JM, Siminovitch KA (1999) Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med 190:1329–1342PubMedGoogle Scholar
  348. 348.
    Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, Chen SH, Ochs HD (1995) The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86:3797–3804PubMedGoogle Scholar
  349. 349.
    Zinsser F (1906) Atropha cutis reticularis cum pigmentatione, dystrophia ungium et leukoplakia oris. Ikonogr Dermatol (Hyoto) 5:219–223Google Scholar
  350. 350.
    Zuccarello D, Salpietro DC, Gangemi S, Toscano V, Merlino MV, Briuglia S, Bisignano G, Mangino M, Mingarelli R, Dallapiccola B (2002) Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis. J Med Genet 39:671–675PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Mehdi Yeganeh
    • 1
  • Eleonora Gambineri
    • 2
  • Kamran Abolmaali
    • 3
  • Banafshe Tamizifar
    • 4
  • Teresa Español
    • 5
  1. 1.Immunology, Asthma and Allergy Research Institute Children’s Medical Center HospitalTehran University of Medical SciencesTehranIran
  2. 2.Department of PediatricsUniversity of Florence “Anna Meyer” Children’s HospitalFirenzeItaly
  3. 3.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  4. 4.Department of Dermatology Razi HospitalTehran University of Medical SciencesTehranIran
  5. 5.Immunology UnitVall d’Hebron University HospitalBarcelonaSpain

Personalised recommendations